Compare Cassava Sciences Inc (FLNA) vs MasTec Inc (MTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs MasTec Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while MasTec Inc trades at $277.54 (market cap $21.90B). The key difference: MasTec Inc is far larger — about 458.6× Cassava Sciences Inc's market cap, and MasTec Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | MTZ | |
|---|---|---|
Market Cap | $47.75M | $21.90B |
Sector | Health | Technology |
52-Week High | $4.64 | $437.51 |
52-Week Low | $0.87 | $172.51 |
Enterprise Value | -$34.93M | $24.81B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →
